Sinophare Biotechnology
Human Medicines
Expert R&D, Reliable Custom Products
Sinophare supplies a full range of WHO-standard anti-malarial medicines, mainly artemisinin-based combination therapies (ACTs) and classic malaria treatment drugs. All products comply with cGMP production standards, widely exported to Africa, Southeast Asia and other malaria-endemic areas.
Our products cover injections, oral tablets, suspensions and suppositories, suitable for adult, pediatric use, common malaria treatment, severe malaria rescue and malaria prevention. Featuring stable curative effect, fast onset and complete specifications, they are first-choice medicines for global malaria control.
